Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLG) EBT Margin (2016 - 2017)

Bone Biologics (BBLG) has disclosed EBT Margin for 2 consecutive years, with 106.36% as the latest value for Q2 2017.

  • On a quarterly basis, EBT Margin fell 141114.0% to 106.36% in Q2 2017 year-over-year; TTM through Dec 2017 was 410.02%, a 211170.0% decrease, with the full-year FY2025 number at 2471.56%, up 142900.0% from a year prior.
  • EBT Margin was 106.36% for Q2 2017 at Bone Biologics, down from 383.36% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 3954.41% in Q1 2016 to a low of 106.36% in Q2 2017.